Close

CONGRESSIONAL BIOTECHNOLOGY BRIEFING - JUNE 6, 2001 by Millennium Pharmaceuticals, Inc.

Jun 4 2001
WASHINGTON, D.C. (June 4, 2001) – Millennium Pharmaceuticals, Inc. is conducting a congressional breakfast briefing on biotechnology on June 6, at 8:30 a.m. in Room B-340 of Rayburn House Office...

EARLY MEDIA REGISTRATION FOR BIO 2001 ENDS JUNE 1

May 31 2001
WASHINGTON, D.C. (May 31, 2001) – Advance media registration for BIO 2001, recommended for all reporters and editors and required for freelance journalists, ends tomorrow, June 1. Registration is...

EARLY MEDIA REGISTRATION FOR BIO 2001 ENDS JUNE 1

May 23 2001
WASHINGTON, D.C. (May 23, 2001) – Advance media registration for BIO 2001, recommended for all reporters and editors and required for freelance journalists, ends June 1. Registration is...

BIO TO LAUNCH FIRST NATIONAL VENTURE FORUM FOCUSED EXCLUSIVELY ON BIOTECH

May 23 2001
Premier Event Unites Investors and Biotechnology Entrepreneurs

Washington, D.C. (May 23, 2001) – The Biotechnology Industry Organization (BIO) will host its first annual BIO VentureForum on...

BIO Seeks Clinical Trial Reforms To Protect Patients And Encourage Research

May 22 2001
Washington, D.C. (May 22, 2001) – Bernice Welles, M.D., will speak on behalf of the Biotechnology Industry Organization Wednesday at a Senate hearing to discuss possible reforms of the system of...

NATIONAL ENERGY POLICY SHOWS COMMITMENT TO BIOBASED ENERGY

May 17 2001
WASHINGTON, D.C. (May 17, 2001) – Skyrocketing gasoline, home heating oil and natural gas prices underscore the importance of developing renewable energy sources. The Biotechnology Industry...

MEDIA ADVISORY - Bioenergy Facts

May 16 2001
WASHINGTON, D.C. (May 16, 2001) -- It is likely that PresidentBush and Vice President Cheney will include bioenergy development in their new energy policy.

Please find some background facts below...

BIOTECHNOLOGY INDUSTRY REPRESENTATIVE TO TESTIFY ON MEDICARE PRESCRIPTION DRUG BENEFIT

May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the Biotechnology Industry Organization ...

BIOLOGIC PRODUCTS SHOULD NOT BE INCLUDED IN USP FOR MEDICARE COVERAGE

May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in response to a Medicare reform press...

Biotechnology CEOs Spread Message On Capitol Hill and Present Legislator of the Year Awards at BIO Legislative Day, May 15-16

May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the Biotechnology Industry Organization’s ...